[250 Pages Report] The global copovidone market is estimated to register remarkable growth, expanding at a CAGR of around 9% to 10% during the forecast period 2022-2032. Increasing demand for non-toxic, and pharmaceutically inactive thickening and binding agents across diverse industries is expected to accelerate the sales of copovidone in the global market.
| Report Attribute | Details |
|---|---|
| Copovidone Market Projected Growth Rate (2022 to 2032) | 9% to 10% CAGR |
Copovidone is an analog of povidone which is commonly used as a fining agent, tablet binder, emulsifier, and a part of matrix materials in controlled-release formulations. This compound is increasingly used as an alternative to povidone, owing to its less hygroscopic, more elastic, and better plasticity attributes in comparison to povidone.
Copovidone is gaining huge traction as a film-forming agent and is being added to the coating solutions for enhancing its adhesion, elasticity, and hardness. It is finding a wide range of applications across various sectors such as industrial, ceramics, adhesives, battery, and others, on account of several benefits, it offers over other polymers. This is projected to accelerate the sales of copovidone in the global market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market for copovidone is largely driven by favorable government regulations, policies, and standards. Numerous regulatory organization such as the U.S. Food & Drug Administration has approved using non-toxic and pharmaceutically inactive chemicals such as copovidone across industries such as food & beverage, pharmaceuticals, and personal care & cosmetics.
This, in addition to its excellent moisture barrier and binder properties, copovidone is finding usages as a soluble binder for gelatin capsules and as a dry binder for direct compression tableting across pharmaceutical industry. Hence, growing demand for tablets, pills, and capsules across the globe is projected to create lucrative growth opportunities in the copovidone market.
In the past couple of years, a rapid inclination towards the adoption of organic and natural cosmetics & personal care products is being witnessed, especially across developed countries such as the U.S., Germany, Japan, the U.K., and others. This is discouraging the industry players from making use of copovidone in their products, thereby, hampering the demand in the market.
Also, side effects associated with excessive consumption of copovidone such as stomach aches, nausea, diarrhea, and vomiting are further hindering the sales in the market.
Principal Consultant
South Asia is expected to account for a significant share in the global copovidone market from 2022 to 2032, reveals Future Market Insights.
Demand for therapeutic drugs such as tablets and pills is increasing at a rapid pace in South Asia, on account growing burden of numerous diseases and increasing adoption of personalized medicine. Hence, leading industry players are emphasizing on expanding their drugs production capacity to cater to this surging demand.
For instance, in 2021, Glenmark Life Science, an Indian manufacturer of drugs and therapeutics products announced its plan of investing around US$ 78.7 Mn for increasing its production capacity to more than double in the coming years. As copovidone is extensively used in capsules, tablets, and pills production, such developments are estimated to bolster the growth in the South Asia market.
A study by FMI states that North America is anticipated to register growth at a rapid CAGR in the global copovidone market during the forecast period 2022-2032.
Due to the increasing concerns regarding personal hygiene and growing consumer spending on enhancing the facial, body, and hair aesthetic, a substantial rise in sales of personal care & cosmetics products is being witnessed across North America.
As copovidone is extensively used as an emulsifier, binder, and thickening agent in the products such as toothpaste, moisturizers, shampoos, shaving lotions, and others, growing sales of these products are projected to augment the demand in the North America market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the leading players in the copovidone market profiled by FMI are Nanhang Industrial, Merck KGaA, Boai NKY Pharmaceuticals Ltd., BASF SE, Huangshan Bonsun Pharmaceuticals Co., Ltd., Ashland, Hangzhou Motto Science & Technology Co. Ltd., Shanghai Yuking Water Soluble Material Tech Co. Ltd., and others.
The market for copovidone is highly competitive, attributed to increasing research and development activities for launching novel products and adoption of production capacity expansion strategies by key companies.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 9% to 10% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Billion and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Countries Covered |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
FMI projects the sales of copovidone in the market is expected to rise at 9% to 10% value CAGR by 2032
The global copovidone market is expected to be dominated by the pharmaceutical industry over forecast period 2022-2032.
Nanhang Industrial, Merck KGaA, Boai NKY Pharmaceuticals Ltd., BASF SE, Huangshan Bonsun Pharmaceuticals Co., Ltd., Ashland, Hangzhou Motto Science & Technology Co. Ltd., Shanghai Yuking Water Soluble Material Tech Co. Ltd., others are some of the leading players in the prominent copovidone market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. Value Chain Analysis 3.5.1. Profit Margin Analysis 3.5.2. Service Providers 3.6. PESTLE and Porter’s Analysis 3.7. Regulatory Landscape 3.7.1. By Key Regions 3.7.2. By Key Countries 3.8. Regional Parent Market Outlook 4. Global Copovidone Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Copovidone Market Analysis 2017-2021 and Forecast 2022-2032, By Grade Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Grade Type , 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Grade Type , 2022-2032 5.3.1. Food Grade 5.3.2. Pharmaceutical Grade 5.3.3. Cosmetic Grade 5.4. Y-o-Y Growth Trend Analysis By Grade Type , 2017-2021 5.5. Absolute $ Opportunity Analysis By Grade Type , 2022-2032 Deep-dive segmentation will be available in the sample on request 6. Global Copovidone Market Analysis 2017-2021 and Forecast 2022-2032, By Form 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By Form, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Form, 2022-2032 6.3.1. Liquid 6.3.2. Powder 6.4. Y-o-Y Growth Trend Analysis By Form, 2017-2021 6.5. Absolute $ Opportunity Analysis By Form, 2022-2032 Deep-dive segmentation will be available in the sample on request 7. Global Copovidone Market Analysis 2017-2021 and Forecast 2022-2032, By Functionality 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) Analysis By Functionality, 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Functionality, 2022-2032 7.3.1. Granulating Agent 7.3.2. Retarding Agent 7.3.3. Film-forming Agent 7.3.4. Lubricant 7.3.5. Thickening Agent 7.3.6. Dispersant 7.3.7. Binding Agent 7.3.8. Emulsifying Agent 7.3.9. Fining Agent 7.3.10. Blocking Agent 7.3.11. Other Functionalities 7.4. Y-o-Y Growth Trend Analysis By Functionality, 2017-2021 7.5. Absolute $ Opportunity Analysis By Functionality, 2022-2032 Deep-dive segmentation will be available in the sample on request 8. Global Copovidone Market Analysis 2017-2021 and Forecast 2022-2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. East Asia 8.3.5. South Asia & Pacific 8.3.6. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Copovidone Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Grade Type 9.2.3. By Form 9.2.4. By Functionality 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Grade Type 9.3.3. By Form 9.3.4. By Functionality 9.4. Key Takeaways 10. Latin America Copovidone Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Mexico 10.2.1.2. Brazil 10.2.1.3. Rest of Latin America 10.2.2. By Grade Type 10.2.3. By Form 10.2.4. By Functionality 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Grade Type 10.3.3. By Form 10.3.4. By Functionality 10.4. Key Takeaways 11. Europe Copovidone Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. Italy 11.2.1.3. France 11.2.1.4. U.K. 11.2.1.5. Spain 11.2.1.6. BENELUX 11.2.1.7. Russia 11.2.1.8. Rest of Europe 11.2.2. By Grade Type 11.2.3. By Form 11.2.4. By Functionality 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Grade Type 11.3.3. By Form 11.3.4. By Functionality 11.4. Key Takeaways 12. East Asia Copovidone Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.2. By Grade Type 12.2.3. By Form 12.2.4. By Functionality 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Grade Type 12.3.3. By Form 12.3.4. By Functionality 12.4. Key Takeaways 13. South Asia & Pacific Copovidone Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. India 13.2.1.2. ASEAN 13.2.1.3. Australia and New Zealand 13.2.1.4. Rest of South Asia & Pacific 13.2.2. By Grade Type 13.2.3. By Form 13.2.4. By Functionality 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Grade Type 13.3.3. By Form 13.3.4. By Functionality 13.4. Key Takeaways 14. MEA Copovidone Market Analysis 2017-2021 and Forecast 2022-2032, By Country 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. Turkey 14.2.1.3. South Africa 14.2.1.4. Rest of MEA 14.2.2. By Grade Type 14.2.3. By Form 14.2.4. By Functionality 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Grade Type 14.3.3. By Form 14.3.4. By Functionality 14.4. Key Takeaways 15. Key Countries Copovidone Market Analysis 15.1. U.S. 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2021 15.1.2.1. By Grade Type 15.1.2.2. By Form 15.1.2.3. By Functionality 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2021 15.2.2.1. By Grade Type 15.2.2.2. By Form 15.2.2.3. By Functionality 15.3. Mexico 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2021 15.3.2.1. By Grade Type 15.3.2.2. By Form 15.3.2.3. By Functionality 15.4. Brazil 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2021 15.4.2.1. By Grade Type 15.4.2.2. By Form 15.4.2.3. By Functionality 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2021 15.5.2.1. By Grade Type 15.5.2.2. By Form 15.5.2.3. By Functionality 15.6. Italy 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2021 15.6.2.1. By Grade Type 15.6.2.2. By Form 15.6.2.3. By Functionality 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2021 15.7.2.1. By Grade Type 15.7.2.2. By Form 15.7.2.3. By Functionality 15.8. U.K. 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2021 15.8.2.1. By Grade Type 15.8.2.2. By Form 15.8.2.3. By Functionality 15.9. Spain 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2021 15.9.2.1. By Grade Type 15.9.2.2. By Form 15.9.2.3. By Functionality 15.10. BENELUX 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2021 15.10.2.1. By Grade Type 15.10.2.2. By Form 15.10.2.3. By Functionality 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2021 15.11.2.1. By Grade Type 15.11.2.2. By Form 15.11.2.3. By Functionality 15.12. China 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2021 15.12.2.1. By Grade Type 15.12.2.2. By Form 15.12.2.3. By Functionality 15.13. Japan 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2021 15.13.2.1. By Grade Type 15.13.2.2. By Form 15.13.2.3. By Functionality 15.14. South Korea 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2021 15.14.2.1. By Grade Type 15.14.2.2. By Form 15.14.2.3. By Functionality 15.15. India 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2021 15.15.2.1. By Grade Type 15.15.2.2. By Form 15.15.2.3. By Functionality 15.16. ASEAN 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2021 15.16.2.1. By Grade Type 15.16.2.2. By Form 15.16.2.3. By Functionality 15.17. Australia and New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2021 15.17.2.1. By Grade Type 15.17.2.2. By Form 15.17.2.3. By Functionality 15.18. GCC Countries 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2021 15.18.2.1. By Grade Type 15.18.2.2. By Form 15.18.2.3. By Functionality 15.19. Turkey 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2021 15.19.2.1. By Grade Type 15.19.2.2. By Form 15.19.2.3. By Functionality 15.20. South Africa 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2021 15.20.2.1. By Grade Type 15.20.2.2. By Form 15.20.2.3. By Functionality 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Grade Type 16.3.3. By Form 16.3.4. By Functionality 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Jianhua Group 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. Merck KGaA 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. Boai NKY Pharmaceuticals Ltd. 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. BASF SE 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. Ashland, Hangzhou Motto Science & Technology Co. Ltd. 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. Shanghai Yuking Water Soluble Material Tech Co. Ltd. 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Food and Beverage Insights
View Reports
Copovidone Market
